Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
29
2024
Weekly IRS Roundup February 19 – February 23, 2024 McDermott Will & Emery
Feb
29
2024
District Court Elucidates the Meaning of “to Induce” Under the Federal Health Care Program Anti-Kickback Statute Sheppard, Mullin, Richter & Hampton LLP
Feb
29
2024
Navigating the Regulatory Maze: Understanding the ASA Ruling re. Supreme CBD Squire Patton Boggs (US) LLP
Feb
28
2024
Federal Court Ruling Suspends Compliance with Certain Reporting Obligations Under Oregon Drug Price Transparency Program ArentFox Schiff LLP
Feb
28
2024
Library of Congress Publishes Article on South Korea’s Act on Promoting the Green Bio Industry Bergeson & Campbell, P.C.
Feb
28
2024
Senator Sanders Calls for Robust Front of Pack Labeling Requirements Keller and Heckman LLP
Feb
28
2024
Understanding the Risks Associated with Social Media Marketing Foley & Lardner LLP
Feb
27
2024
CMS Releases Part Two of Guidance for the Inflation Reduction Act’s Medicare Prescription Payment Plan Mintz
Feb
27
2024
FDA 2023-24: A Look Back & A Peek Forward Polsinelli PC
Feb
27
2024
Family Dollar Pleads Guilty to Food and Drug Adulteration Charge Keller and Heckman LLP
Feb
27
2024
FDA Releases Updated Directory on Select Dietary Supplement Ingredients Epstein Becker & Green, P.C.
Feb
27
2024
This Week in 340B: February 21 – 26, 2024 McDermott Will & Emery
Feb
27
2024
This Week in 340B: February 14 – 20, 2024 McDermott Will & Emery
Feb
26
2024
2023 Health Care Employment Law Year in Review K&L Gates
Feb
26
2024
Court Finds Access to Botox Trade Secrets and Similarity of Competitor Product Supported Inference of Trade Secrets Misappropriation Proskauer Rose LLP
Feb
26
2024
ISTAND Pilot Program Accepts First AI-Based Digital Health Technology Greenberg Traurig, LLP
Feb
26
2024
Mallinckrodt Trust Asserts Novel Argument in Response to Safe Harbor Defense (US) Squire Patton Boggs (US) LLP
Feb
23
2024
High Stakes: New Proposed Philadelphia Ordinance Regulating Skill-Based Games at Odds with State Police Cases Norris McLaughlin P.A.
Feb
23
2024
ECHA Begins Public Consultation on Recommending Authorization for Five SVHCs and Adding a New Hazard to DBP Bergeson & Campbell, P.C.
Feb
23
2024
EPA and DOE Announce Funding to Spur Development of Advanced Biofuels Bergeson & Campbell, P.C.
Feb
23
2024
FDA Issues Guidance on Voluntary Premarket Engagement for Foods Derived from Plants Produced Using Genome Editing Keller and Heckman LLP
Feb
22
2024
Mixed Beverage Definition Gaining Traction in Indiana McDermott Will & Emery
Feb
22
2024
Mintz IRA Update — Legal Challenges to the Medicare Drug Price Negotiation Program Continue Mintz
Feb
22
2024
Mintz IRA Update — The IRA in 2024: The Medicare Drug Price Negotiation Program in Full Swing and Other Developments Mintz
Feb
22
2024
A Guide for FDA Whistleblowers Oberheiden P.C.
Feb
22
2024
Regulatory Certainty for Biosimilars in Mexico OLIVARES
Feb
22
2024
Top Legal Considerations for the GCs and CFOs in the Life Sciences Industry in 2024 ArentFox Schiff LLP
Feb
21
2024
FDA Launches New Directory of Ingredients Used in Dietary Supplements Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins